Full name: Mireia Moreno
Current country: Spain
Membership level: Full
Type of membership: Member
Number of publications: 23
Hidradenitis Suppurativa from a MultiOmic Scope (2025)
https://pubmed.ncbi.nlm.nih.gov/39487752/
Active hand inflammation. Differing clinical and ultrasound patterns in patients with rheumatoid arthritis and psoriatic arthritis – A Cross-Sectional, Multicenter Study (2025)
https://pubmed.ncbi.nlm.nih.gov/40316201/
Usefulness of ultrasound in the assessment of the efficacy of apremilast in psoriatic arthritis: Articular, enthesitic and nail index (2025)
https://pubmed.ncbi.nlm.nih.gov/40921515/
Efficacy of withdrawal or tapering of bDMARDs vs. standard regiment in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline (2025)
https://pubmed.ncbi.nlm.nih.gov/41001393/
Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 study (2025)
https://pubmed.ncbi.nlm.nih.gov/41052888/
Screening for Inflammatory Chronic Arthritis in Hidradenitis Suppurativa with Psoriatic Arthritis Uncluttered Screening Evaluation (PURE) Questionnaire (2025)
https://pubmed.ncbi.nlm.nih.gov/40698345/
Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis:A Multicenter Case–Control Study. (2025)
https://pubmed.ncbi.nlm.nih.gov/41164894/
Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO (2022)
https://pubmed.ncbi.nlm.nih.gov/35063018/
Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34876490/
Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32007930/
Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists (2020)
https://pubmed.ncbi.nlm.nih.gov/33146762/
Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA (2020)
https://pubmed.ncbi.nlm.nih.gov/32251735/
Ultrasound Assessment of Psoriatic Onychopathy: A Cross-sectional Study Comparing Psoriatic Onychopathy with Onychomycosis (2019)
https://pubmed.ncbi.nlm.nih.gov/30281142/
Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study (2019)
https://pubmed.ncbi.nlm.nih.gov/30953541/
Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study (2019)
https://pubmed.ncbi.nlm.nih.gov/31558361/
Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice (2019)
https://pubmed.ncbi.nlm.nih.gov/31535169/
Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database (2018)
https://pubmed.ncbi.nlm.nih.gov/30285828/
Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides) (2018)
https://pubmed.ncbi.nlm.nih.gov/29745878/
The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study (2018)
https://pubmed.ncbi.nlm.nih.gov/29786781/
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29111261/
Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain (2017)
https://pubmed.ncbi.nlm.nih.gov/28389856/
Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs? (2016)
https://pubmed.ncbi.nlm.nih.gov/26812050/
A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis (2014)
https://pubmed.ncbi.nlm.nih.gov/24657116/